Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-24-028073

PRESIDENT AND CEO acquired 3,901 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · PRESIDENT AND CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-30 Grant or award : show line 1 in the form +3,901 $2.10 $8,192 500,597 D
Loading xslF345X05/form4-12032024_041201.xml…